4 completed. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Brimonidine: new trials by email Literature Review of Brimonidine trials Research Report on Brimonidine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia Aceclidine+Brimonidine combination ophthalmic solution, Aceclidine ophthalmic solution, Brimonidine - Presbyopia, Refractive Error | Phase 3 | Completed | LENZ Therapeutics, Inc | 469 | 2022-12-19 | 2026-05-13 |
| Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With Rosacea Brimonidine, placebo - Rosacea | Phase 3 | Completed | Actavis Inc. | 462 | 2014-07-01 | 2020-01-14 |
| Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy COLIRIOBCN070660, Placebo, Brimonidine - Diabetic Retinopathy | Phase 2 / Phase 3 | Completed | BCN Peptides | 450 | 2013-02-01 | 2016-01-12 |
| Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension brimonidine - Glaucoma, Ocular Hypertension | Phase 3 | Completed | Allergan | 207 | 2005-01-01 | 2011-05-30 |
Diabetic Retinopathy (1) · Eye Diseases (1) · Glaucoma (1) · Myopia (1) · Ocular Hypertension (1) · Presbyopia (1) · Refractive Errors (1) · Rosacea (1)
Actavis Inc. (1) · Allergan (1) · BCN Peptides (1) · LENZ Therapeutics, Inc (1)
United States (2) · Denmark (1) · France (1) · Germany (1) · Italy (1) · Portugal (1) · Spain (1) · United Kingdom (1)
Kris Gambelin, BS (1) · Nageshwar R Thudi, Ph.D. (1)